Matthew Reynolds to Defibrillators, Implantable
This is a "connection" page, showing publications Matthew Reynolds has written about Defibrillators, Implantable.
Connection Strength
5.756
-
Maron BJ, Estes NAM, Rowin EJ, Maron MS, Reynolds MR. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023 07 25; 82(4):353-373.
Score: 0.652
-
Griffiths RI, Amorosi SL, Jacobsen CM, McBee PJ, Menzin J, Reynolds MR. Costs and complications associated with transvenous lead reoperation in cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2020 02; 31(2):503-511.
Score: 0.512
-
Turakhia MP, Zweibel S, Swain AL, Mollenkopf SA, Reynolds MR. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks. Circ Cardiovasc Qual Outcomes. 2017 02; 10(2).
Score: 0.417
-
Ladapo JA, Turakhia MP, Ryan MP, Mollenkopf SA, Reynolds MR. Health Care Utilization and Expenditures Associated With Remote Monitoring in Patients With Implantable Cardiac Devices. Am J Cardiol. 2016 May 01; 117(9):1455-62.
Score: 0.390
-
Kramer DB, Mitchell SL, Monteiro J, Jones PW, Normand SL, Hayes DL, Reynolds MR. Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study. J Am Heart Assoc. 2015 May 15; 4(5).
Score: 0.370
-
Charytan DM, Reynolds MR. Do implantable defibrillators help patients with CKD? Am J Kidney Dis. 2014 Jul; 64(1):4-6.
Score: 0.348
-
Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014 Feb; 11(2):216-21.
Score: 0.338
-
Reynolds MR, Zimetbaum P. Magnetic resonance imaging and cardiac devices: how safe is safe enough? Ann Intern Med. 2011 Oct 04; 155(7):470-2.
Score: 0.288
-
Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Jun 20; 47(12):2493-7.
Score: 0.199
-
Reynolds MR, Joventino LP, Josephson ME. Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure. Pacing Clin Electrophysiol. 2004 Nov; 27(11):1513-8.
Score: 0.178
-
Reynolds MR, Josephson ME. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation. 2003 Oct 14; 108(15):1779-83.
Score: 0.166
-
Resnic FS, Majithia A, Dhruva SS, Ssemaganda H, Robbins S, Marinac-Dabic D, Hewitt K, Ohno-Machado L, Reynolds MR, Matheny ME. Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e006105.
Score: 0.130
-
Field ME, Goldstein L, Yu Lee SH, Kalsekar I, Coplan P, Wong C, Khanna R, Gold MR, Reynolds MR, Winterfield JR. Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia. J Comp Eff Res. 2020 04; 9(5):375-385.
Score: 0.129
-
Kramer DB, Habtemariam D, Adjei-Poku Y, Samuel M, Engorn D, Reynolds MR, Mitchell SL. The Decisions, Interventions, and Goals in ImplaNtable Cardioverter-DefIbrillator TherapY (DIGNITY) Pilot Study. J Am Heart Assoc. 2017 Sep 22; 6(9).
Score: 0.109
-
Basil A, Lubitz SA, Noseworthy PA, Reynolds MR, Gold H, Yassa D, Kramer D. Periprocedural Antibiotic Prophylaxis for Cardiac Implantable Electrical Device Procedures: Results From a Heart Rhythm Society Survey. JACC Clin Electrophysiol. 2017 06; 3(6):632-634.
Score: 0.107
-
Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL. Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry. J Am Geriatr Soc. 2017 Feb; 65(2):340-347.
Score: 0.102
-
Hatfield LA, Kramer DB, Volya R, Reynolds MR, Normand SL. Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure. J Am Heart Assoc. 2016 07 28; 5(8).
Score: 0.100
-
Kramer DB, Reynolds MR, Normand SL, Parzynski CS, Spertus JA, Mor V, Mitchell SL. Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry. Circulation. 2016 May 24; 133(21):2030-7.
Score: 0.098
-
Nazarian S, Reynolds MR, Ryan MP, Wolff SD, Mollenkopf SA, Turakhia MP. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging. 2016 Jan; 43(1):115-27.
Score: 0.093
-
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Response to letter regarding article, "Rates of and factors associated with infection in 200?909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry". Circulation. 2015 Jun 02; 131(22):e518.
Score: 0.093
-
Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):437-46.
Score: 0.093
-
Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014 Sep 23; 130(13):1037-43.
Score: 0.088
-
Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014 Jun 15; 113(12):2052-6.
Score: 0.086
-
Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2014 Mar 04; 63(8):788-96.
Score: 0.084
-
Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):488-97.
Score: 0.081
-
Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm. 2013 Apr; 10(4):e59-65.
Score: 0.079
-
Abdelhadi RH, Saba SF, Ellis CR, Mason PK, Kramer DB, Friedman PA, Gura MT, DiMarco JP, Mugglin AS, Reynolds MR, Bazaz RR, Retel LK, Hayes DL, Hauser RG. Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm. 2013 Mar; 10(3):361-5.
Score: 0.078
-
Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012 Apr 23; 172(8):634-41; discussion 641.
Score: 0.075
-
Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm. 2012 Jan; 9(1):42-6.
Score: 0.072
-
Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010 Sep; 7(9):1340-5.
Score: 0.066
-
Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007 Dec 27; 357(26):2657-65.
Score: 0.055
-
Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol. 2006 Sep; 17(9):940-3.
Score: 0.051
-
Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. J Am Coll Cardiol. 2010 Aug 31; 56(10):766-73.
Score: 0.017
-
Tung R, Josephson ME, Reddy V, Reynolds MR. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol. 2010 Jul; 21(7):799-803.
Score: 0.016